News
PALO ALTO, CA / ACCESS Newswire / May 30, 2025 / Riboscience, LLC, today announced the presentation of data from the completed dose escalation Phase 1a of the Phase 1a/b clinical trial of the ENPP1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback